Zobrazeno 1 - 10
of 306
pro vyhledávání: '"Charles W. Francis"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Venous thromboembolism (VTE) is a common complication in cancer patients, resulting in deep vein thrombosis (DVT) or pulmonary embolism (PE), and is responsible for high morbidity and mortality. This article discusses evidence and future per
Externí odkaz:
https://doaj.org/article/b0ec03b78f204f39a6b9fc05562434ff
Autor:
David R. Anderson, Gian Paolo Morgano, Carole Bennett, Francesco Dentali, Charles W. Francis, David A. Garcia, Susan R. Kahn, Maryam Rahman, Anita Rajasekhar, Frederick B. Rogers, Maureen A. Smythe, Kari A.O. Tikkinen, Adolph J. Yates, Tejan Baldeh, Sara Balduzzi, Jan L. Brożek, Itziar Etxeandia- Ikobaltzeta, Herman Johal, Ignacio Neumann, Wojtek Wiercioch, Juan José Yepes-Nuñez, Holger J. Schünemann, Philipp Dahm
Publikováno v:
Blood Advances, Vol 3, Iss 23, Pp 3898-3944 (2019)
Abstract: Background: Venous thromboembolism (VTE) is a common source of perioperative morbidity and mortality.Objective: These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about preventing
Externí odkaz:
https://doaj.org/article/8e3e6ffbfda94555b2d7712cd5d12dd4
Autor:
Laurence S Magder, PJ Devereaux, Diane Smith, Laurence Magder, David J Warwick, Samuel Z Goldhaber, Jay S Magaziner, James A Browne, John Eikelboom, Rebecca Baron, Patrick Heagerty, Stephen L Kates, Vincent D Pellegrini, Jr, John William Eikelboom, C McCollister Evarts, Patricia D Franklin, Kevin L Garvin, Richard Iorio, Carol Ann Lambourne, Jay Magaziner, Eric M Cohen, Charles M Davis, Navin D Fernando, Kevin B Fricka, Richard J Friedman, Kevin L. Garvin, Michael S Kain, Brent A Lanting, Brock A Lindsey, William J Maloney, Robert M Molloy, Michael A Mont, Wayne E Moschetti, James Nace, Charles L Nelson, Kevin I Perry, James D Slover, Mark J Spangehl, Lawrence M Specht, Scott M Sporer, Robert S Sterling, Zeke J Walton, William L Healy, Charles W Francis, Vincent D Pellegrini, Monica Baczko, Carol A Lambourne, Brook I Martin, Ronald Blankstein, Carolyn Come, Jean Connors, Raymond Kwong, Greg Piazza, Rachel Rosovsky, Aaron Waxman, Roger Bulger, Ruth Bulger, Mary Beth Crummer, Debra Hamilton, Connie Persels, Robert Schlegel, Sally Seeley, Mitchell Thompson, Teresa Bordeaux, Kathryn Z Mikkelsen, Lisa K Moores
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction More than 1 million elective total hip and knee replacements are performed annually in the USA with 2% risk of clinical pulmonary embolism (PE), 0.1%–0.5% fatal PE, and over 1000 deaths. Antithrombotic prophylaxis is standard of care b
Externí odkaz:
https://doaj.org/article/c21d8bdb9eae4552a920adbd09818605
Autor:
James Ryan Loftus, Deborah J. Rubens, Burke R Morin, Zhongxia Hu, Katherine Kaproth-Joslin, Charles W. Francis, Alok A. Khorana, Susan K. Hobbs
Publikováno v:
Journal of Ultrasound in Medicine. 41:225-236
Objectives We retrospectively examined the venous thromboembolism (VTE) events diagnosed in the Prophylaxis of High-Risk Ambulatory Cancer Patients Study (PHACS), a multi-center randomized trial, to assess the value of screening vascular imaging for
Autor:
Fisseha Tesfaye, Michael R. Lassen, John Strony, Renée M Swaim, Jeffrey I. Weitz, Gary Peters, Gary E. Raskob, Lee Michael, Peter M DiBattiste, Charles W. Francis, Annelise Segers, Takeshi Fuji, Robin S. Roberts
Publikováno v:
Journal of Thrombosis and Haemostasis
BACKGROUND JNJ-9375 is an antibody against exosite 1 on thrombin, inhibits substrate binding but not catalytic activity. OBJECTIVE To examine the possibility that JNJ-9375 attenuates thrombosis without affecting hemostasis, we compared the efficacy a
Autor:
Alok A. Khorana, Charles W. Francis
Publikováno v:
Thrombosis Research. 164:S70-S76
Cancer-associated venous thromboembolism (VTE) has major consequences for patients, including morbidity and risk of mortality. However, there is substantial variation in risk depending on a multitude of clinical risk factors and many cancer patients
Autor:
Grace Conley, Saadia Sherazi, Eugene Muchnik, Brent A. Johnson, Peter A. Kouides, H.T. Massey, Charles W. Francis, Charles J. Lowenstein, Majed A. Refaai, Jeffrey D. Alexis, Susan Lien
Publikováno v:
The International Journal of Artificial Organs. 41:269-276
Background: Bleeding is a major cause of morbidity in patients with continuous flow left ventricular assist devices (LVADs). We sought to identify clinical predictors of bleeding within the first year of LVAD implantation. Methods: A prospective stud
Autor:
Brynja R. Gudmundsdottir, Olafur S. Indridason, Pall T. Onundarson, Charles W. Francis, Hulda M. Jensdottir, David O. Arnar, Brynjar Vidarsson, Sigrun H. Lund, Alma R. Oskarsdottir, Magnus K. Magnusson, Einar Bjornsson
Publikováno v:
Journal of Thrombosis and Thrombolysis. 43:550-561
Fiix-prothrombin time (Fiix-PT) differs from traditional PT in being affected by reduced factor (F) II or FX only. In the randomized controlled Fiix-trial, patients on warfarin monitored with Fiix-PT (Fiix-warfarin patients) had fewer thromboembolism
Publikováno v:
International Journal of Laboratory Hematology. 39:e10-e13
Autor:
Pall T. Onundarson, Brynja R. Gudmundsdottir, Sigurdur Juliusson, Petur I. Jonsson, Charles W. Francis, Loic Letertre
Publikováno v:
Journal of Thrombosis and Haemostasis. 15:131-139
Background The prothrombin time (PT) is equally prolonged by reduction in each of vitamin K dependent (VKD) factors (F) II, VII and X. The Fiix-PT is only affected by FII and FX, the main contributors to thrombin generation (TG). Objective To test th